Abstract:Abstract 3686 In the International Consensus Report (Rodeghiero et al. Blood 2009;113:2386-2393), platelet transfusions are only recommended in patients with auto-immune thrombocytopenia (ITP) as an adjunctive therapy for life-threatening bleeding. However, the clinical evidence of post-transfusion increments in ITP suggests that in some cases of ITP, platelet transfusions may be a useful prophylactic therapy. To understand the importance of platelet transfusion in this setting, we utilized our murine model of ITP that demonstrates both antibody- and CTL-mediated thrombocytopenia. BALB/c CD61 knockout (KO) mice were immunized by transfusions of three different platelet populations that were either single antigen positive (e.g. CD61+ or MHC class I+) or double antigen positive (CD61+/MHC class I+). Splenocytes from the immune KO mice were either not depleted (ND) or depleted of CD19+ B cells and then transferred into SCID mice and the development of thrombocytopenia and bleeding diathesis was monitored. When ND splenocytes from MHC class I+ immune KO mice were transferred, no thrombocytopenia or bleeding was observed. In contrast, transfer of ND splenocytes from CD61+ immune mice induced a significant thrombocytopenia with a bleeding mortality of 40% within 3 weeks post-transfer; depletion of B cells was used to analyze CD8+ T cell- mediated thrombocytopenia and these depleted splenocytes also induced thrombocytopenia and bleeding. In addition, compared with healthy mice, the bone marrow of the transferred mice showed elevated numbers of megakaryocytes with some of them appearing to be apoptotic. On the other hand, when splenocytes from the double immunized (CD61+/MHC class I+) mice were transferred, the CD8+ T cell- mediated thrombocytopenia and bleeding mortality was not observed. In addition to preventing the thrombocytopenia and bleeding, histological analysis of the bone marrow showed normal numbers of megakaryocytes. These results suggest that both antibody- and CD8+ T cell-mediated immune thrombocytopenia exist and that when anti-CD61 specific CD8+ T cells interacted with allogeneic MHC antigens on platelets they were prevented from inducing CD8+ T cell-mediated thrombocytopenia. Thus, allogeneic MHC platelet transfusions may be responsible for inhibiting CD8+ T cell-mediated thrombocytopenia and may be a therapeutic option for those patients who suffer from cell-mediated ITP. Disclosures: No relevant conflicts of interest to declare.

Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse

Platelets Play a Dual Role in the Pathophysiology of Transfusion-Related Acute Lung Injury

Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury

Plasma From Stored Packed Red Blood Cells And Mhc Class I Antibodies Causes Acute Lung Injury In A 2-Event In Vivo Rat Model

Plasma and lipids from stored platelets cause acute lung injury in an animal model

Platelets Protect Lung from Injury Induced by Systemic Inflammatory Response

Abstract 156: Role of Platelets in Maintaining Hemostasis and Coagulation Activation in Viral-induced Acute Respiratory Distress Syndrome (ards) in Mice

Mechanism and intervention of murine transfusion-related acute lung injury caused by anti-CD36 antibodies

Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions

A pulmonary endothelial amplification loop aggravates ex‐vivo transfusion‐related acute lung injury via increased toll‐like receptor 4 and intra‐cellular adhesion molecule‐1 expression

Crosstalk between neutrophil extracellular traps and immune regulation: insights into pathobiology and therapeutic implications of transfusion-related acute lung injury

Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury

Protective Effect of Platelets Transfusion During Extracorporeal Circulation

Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a

Transfusion of cryopreserved platelets exacerbates inflammatory liver and lung injury in a mice model of hemorrhage.

Allogeneic Platelet MHC Class I Antigens Prevent CD61 Specific Cytotoxic T Cell (Ctl)-Mediated Immune Thrombocytopenia (ITP).

A key role for platelet GPVI in neutrophil recruitment, migration, and NETosis in the early stages of acute lung injury

Allogeneic Platelet Transfusions Prevent Murine T-Cell-Mediated Immune Thrombocytopenia

Abstract 12651: Fine-Tuning of Lung Thrombosis is a Therapeutic Strategy Against Inflammatory Lung Injury

Mechanism of TLR4 mediated immune effect in transfusion-induced acute lung injury based on Slit2/Robo4 signaling pathway

Transfusion-related acute lung injury following random donor platelet transfusion: a report of two cases